BioNTech SE (BNTX) has 6 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 6 sales totalling $36.5M. Most recent filing: Sept. 18, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 18, 2026 filed Sept. 17, 2026 | Sahin Ugur Chief Executive Officer | −$6,239,071 | 64,000 | −12% | Yes | |
|
|
||||||
| Sept. 16, 2026 filed Sept. 15, 2026 | Sahin Ugur Chief Executive Officer | −$4,721,976 | 49,000 | −8% | Yes | |
|
|
||||||
| Sept. 14, 2026 filed Sept. 11, 2026 | Sahin Ugur Chief Executive Officer | −$8,439,336 | 86,000 | −12% | Yes | |
|
|
||||||
| Sept. 11, 2026 filed Sept. 10, 2026 | Sahin Ugur Chief Executive Officer | −$1,974,287 | 20,500 | −3% | Yes | |
|
|
||||||
| Sept. 9, 2026 filed Sept. 8, 2026 | Sahin Ugur Chief Executive Officer | −$7,190,663 | 73,000 | −9% | Yes | |
|
|
||||||
Showing the 5 most recent of 6 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free